Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 4
2005 1
2006 1
2007 1
2008 1
2009 2
2010 4
2011 4
2012 5
2013 2
2014 3
2016 3
2017 7
2018 7
2019 5
2020 7
2021 12
2022 7
2023 5
2024 15
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Pediatric Antiretroviral Therapy.
Dirajlal-Fargo S, Koay WLA, Rakhmanina N. Dirajlal-Fargo S, et al. Among authors: rakhmanina n. Handb Exp Pharmacol. 2020;261:285-323. doi: 10.1007/164_2019_246. Handb Exp Pharmacol. 2020. PMID: 31286213 Review.
Eliminating perinatal HIV in the United States: mission possible?
Gnanashanmugam D, Rakhmanina N, Crawford KW, Nesheim S, Ruel T, Birkhead GS, Chakraborty R, Lawrence R, Jean-Philippe P, Jayashankar L, Hoover A, Statton A, DʼSouza P, Fitzgibbon J, Hazra R, Warren B, Smith S, Abrams EJ. Gnanashanmugam D, et al. Among authors: rakhmanina n. AIDS. 2019 Mar 1;33(3):377-385. doi: 10.1097/QAD.0000000000002080. AIDS. 2019. PMID: 30475262 Free PMC article. Review.
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study.
Rodriguez CA, Natukunda E, Strehlau R, Venter EL, Rungmaitree S, Cunningham CK, Lalloo U, Kosalaraksa P, HellstrÖm E, Liberty A, McGrath EJ, Kaur M, Leisegang R, Hindman JT, Vieira VA, Kersey K, Cotton MF, Rakhmanina N, Gaur AH. Rodriguez CA, et al. Among authors: rakhmanina n. Lancet HIV. 2024 May;11(5):e300-e308. doi: 10.1016/S2352-3018(23)00327-2. Epub 2024 Apr 12. Lancet HIV. 2024. PMID: 38621393 Clinical Trial.
HIV Drug Resistance in Children and Adolescents: Always a Challenge?
Koay WLA, Kose-Otieno J, Rakhmanina N. Koay WLA, et al. Among authors: rakhmanina n. Curr Epidemiol Rep. 2021;8(3):97-107. doi: 10.1007/s40471-021-00268-3. Epub 2021 Mar 18. Curr Epidemiol Rep. 2021. PMID: 33758743 Free PMC article. Review.
Advancing the prevention and treatment of HIV in children: priorities for research and development.
Penazzato M, Townsend CL, Sam-Agudu NA, Ruel TD, Archary M, Bekker A, Cressey TR, Colbers A, Sugandhi N, Rojo P, Rakhmanina N, Watkins M, Frigati L, Mukui I, Hafiz A, Vicari M, Capparelli EV, Abrams EJ; PADO-HIV 5 participants. Penazzato M, et al. Among authors: rakhmanina n. Lancet HIV. 2022 Sep;9(9):e658-e666. doi: 10.1016/S2352-3018(22)00101-1. Epub 2022 Jul 18. Lancet HIV. 2022. PMID: 35863362 Review.
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list.
Penazzato M, Townsend CL, Rakhmanina N, Cheng Y, Archary M, Cressey TR, Kim MH, Musiime V, Turkova A, Ruel TD, Rabie H, Sugandhi N, Rojo P, Doherty M, Abrams EJ; PADO4 participants. Penazzato M, et al. Among authors: rakhmanina n. Lancet HIV. 2019 Sep;6(9):e623-e631. doi: 10.1016/S2352-3018(19)30193-6. Lancet HIV. 2019. PMID: 31498110 Free article. Review.
93 results